Adverse reactions in mRCC patients documented in routine practice by German office-based oncologists and uro-oncologists.

8. Juni 2017

Marschner, N., Müller, L., Münch, A., Blumenstengel, K., Hutzschenreuter, U., Busies, S., 2017.

J Oncol Pharm Pract 23(4), 288–295. doi:10.1177/1078155216632379